Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 2/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1401234 | 0.97 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2HSD17B10MEN1LMNA | |
| SCHEMBL1305795 | 0.97 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2HSD17B10MEN1LMNA | |
| Lithium Ion SCHEMBL1458084 | 0.97 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2HSD17B10MEN1LMNA | |
| Silver SCHEMBL219594 | 0.97 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2HSD17B10MEN1LMNA | |
| SCHEMBL15065488 | 0.97 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2HSD17B10MEN1LMNA | |
| Potassium Ion SCHEMBL1305480 | 0.97 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2HSD17B10MEN1LMNA | |
| SCHEMBL906300 | 0.97 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2HSD17B10MEN1LMNA | |
| Tetramethylammonium Ion SCHEMBL593540 | 0.93 | ALDH1A1 (0.34) | ALDH1A1SMN1; SMN2HSD17B10MEN1LMNA | |
| SCHEMBL6342389 | 0.93 | ALDH1A1 (0.34) | ALDH1A1SMN1; SMN2HSD17B10MEN1LMNA | |
| SCHEMBL447369 | 0.84 | HSD11B1 (0.31) | ALDH1A1SMN1; SMN2HSD17B10MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3323505-B1 | HYDROSILYLATION REACTION CATALYST | UNIV KYUSHU NAT UNIV CORP (JP) | 2024-07-17 | — | — | EP | disclosed |
| CN-107847921-B | Hydrosilylation reaction catalyst | 国立大学法人九州大学 | 2022-01-14 | — | — | CN | disclosed |
| US-20180200703-A1 | HYDROSILYLATION REACTION CATALYST | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2018-07-19 | — | — | US | disclosed |
| EP-3323505-A1 | HYDROSILYLATION REACTION CATALYST | Kyushu University, National University Corporation (JP) | 2018-05-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180200703-A1 | HYDROSILYLATION REACTION CATALYST | CTCF, SLC39A14, SP1 | ALDH1A1 2532/4885SMN1; SMN2 2400/4885HSD17B10 564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.